Skip to main content
. 2020 Oct 11;7(6):4222–4230. doi: 10.1002/ehf2.13053

FIGURE 2.

FIGURE 2

Differences in right ventricular ejection fraction (RVEF) on cardiac magnetic resonance (CMR) at 7 and 30 days following the administration of ferric carboxymaltose in patients included in the Myocardial‐IRON trial. Values are presented as the least square means from each mixed linear regression model. All models were adjusted by hospital (as a cluster variable), the interaction term treatment × visit (7 and 30 days), age, gender, and the baseline (pretreatment) value of the regressed outcome. (A) RVEF differences in all patients. (B) RVEF differences in patients with baseline RVEF < 45%. (C) RVEF differences in patients with RVEF < 51% in women and <52% in men*.